Write your message

Search published articles


Showing 2 results for Doxorubicin

Parastou Rad, Fahimeh Safari, Jamshid Mohammadi, Hamdollah Delaviz,
Volume 15, Issue 1 (1-2021)
Abstract

Background: Chemotherapy agents can cause ovarian dysfunction and eventually lead to infertility. This study investigated the effect of nasturtium officinale extract on the ovarian function following the toxicity induced by doxorubicin in female rats.
Methods: Forty eight female Wistar rats (180-210g) were randomly divided in six groups as follows: Group I, normal rats receiving 1ml normal saline; Group II and III receiving 25 and 75 mg/kg of the extract daily by gavage for 21 days. Groups IV, V and VI receiving 10 mg/kg doxorubicin intraperitoneally on the first day. In addition, Group IV and V received 25 and 75 mg/kg of the extract, respectively. The serum levels of estrogen, progesterone, Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH) and ovarian Malondialdehyde (MDA) were determined after 21 days of treatment. The mean numbers of various graafian follicles and corpus lutea were recorded after treatment.
Results: The mean serum FSH level in Group VI (0.11±0.01) significantly reduced compared to those in Groups II (0.21±0.05) and III (0.23±0.01), (P<0.05). The mean serum LH and estrogen levels in Group VI (0.16±0.08) reduced insignificantly compared to those in the controls (0.21±0.02), and in Groups II (0.23±0.03) and III (0.22±0.09). A significant reduction in the number of primary, secondary and graafian follicles were observed in Group VI compared to the control group (P<0.05). The serum MDA level significantly declined in Group V compared to that in Group VI (P<0.05).
Conclusion: The nasturtium officinale extract attenuated the toxic effect of doxorubicin on the rat ovaries and protected the cell division in the follicles and the oocytes maturation.


Dr. Gabriel Otu Ujong, Dr. Justin Atiang Beshel, Dr. Idara Asuquo Okon, Dr. Clement Ikani Ejim, Dr. Benedict Idam,
Volume 18, Issue 4 (11-2024)
Abstract

Background: A major side effect of some cancer drugs, including Doxorubicin, is cardiotoxicity. This study was designed to evaluate the cardioprotective role of ethanolic leaf extract of Gongronema latifolium (GL) compared to Lisinopril in doxorubicin-induced cardiotoxicity in rats.
Methods: Forty Wistar rats of both sexes (150-200 g) were divided into 5 groups (n=8 each). Group 1 (control) took normal rat chow; Group 2 received 25 mg/kg Doxorubicin; Group 3 received Doxorubicin + GL (200 mg/kg orally); Group 4 received Doxorubicin + Lisinopril (10 mg/kg orally); and Group 5 received Doxorubicin + Lisinopril + GL. The regiment lasted for 28 days. Blood samples were collected from each animal via cardiac puncture for biochemical assays.
Results: The results of the study showed a significant decrease in superoxide dismutase (SOD) concentration in the doxorubicin group as compared to the control group. Intervention with GL and Lisilopril caused a significant increase in SOD concentration. Total antioxidant capacity, catalase, SOD, and angiotensin-II levels were significantly decreased with a corresponding increase in malondialdehyde (MDA) in the Doxorubicin group. Treatment with GL and Lisinopril significantly reversed these changes by increasing the levels of TAC, SOD, CAT, and angiotensin-2 to normal while lowering the MDA levels to normal. Cardiac biomarkers, namely troponin and creatine kinase levels, were significantly increased in the doxorubicin group as compared to the normal control. However, the coadministration of GL and Lisinopril decreased the troponin and creatine kinase concentrations to normal levels.
Conclusions: Gongronema Latifolium and Lisinopril provided better cardioprotective and antioxidant effects versus other agents against cardiotoxicity induced by Doxorubicin.

Page 1 from 1     

© 2025 CC BY-NC 4.0 | Iranian Journal of Toxicology

Designed & Developed by : Yektaweb